iCellate

A Swedish Medtech company active in the field of cancer research and diagnostics, based on detection and analyses of circulating tumor cells (CTC).

[iCellate @iCellate]

#iCellate presenterar den välmeriterade professorn Matthias Löhr från Karolinska Universitetssjukhuset som ny samarbetspartner i det pågående #Horizon2020 projektet, DeteCTC. https://t.co/nEhqfMXQc1

[iCellate @iCellate]

iCellate fortsätter sitt arbete med att validera sin tjänst CellMate® i olika cancertyper. Tillsammans med Capio Urologcentrum Liljeholmen utreds hur bra cirkulerande tumörceller fungerar som markör inom prostatacancer. https://t.co/qugPghUZiV

[iCellate @iCellate]

iCellate har nyligen inkluderats som studiepartner i Metro-studien för analys av biomarkörer i blodet. Studien fokuserar på prostatacancerpatienter med begränsad metastasering. https://t.co/fSCCaRexPj

[iCellate @iCellate]

Amanda invites us in as she navigates the pros and cons of screening and risk-reducing surgery. With strength, courage, and vulnerability, Amanda finds peace and opportunity in her changed body. Read Amanda’s essay #ontheblog. #hereditarycancer #BRCA

https://t.co/vF6flXNieE

[iCellate @iCellate]

Most can’t ever really understand what it’s like to be told we have an 80% risk of cancer. But by reading stories like Amanda’s, we’re reminded that each BRCA-carrier’s experience is unique and complex – and that there is great value in sharing them.

https://t.co/kHLUWnDdgs

[iCellate @iCellate]

A germline (hereditary) mutation in #BRCA1 or #BRCA2 increases cancer risk. But did you know that such a mutation may also qualify certain #cancer patients for treatment with a so-called #PARPinhibitor? Anna Hellquist tells us more #ontheblog

https://t.co/ze4M8Pqbq9

[iCellate @iCellate]

#ontheblog #BRCAcarrier Amanda Frank shares the hurdles that kept her family from accessing #genetictesting sooner.

We are raffling 3 copies of Amanda's #newbook "Leva med cancergenen BRCA"! See instructions for entry on LinkedIn: https://t.co/NZWuvqehqG #BRCA #hereditarycancer

[iCellate @iCellate]

@hilaryosborne reflects on having learned she was a #BRCA carrier, "knowing has empowered me to make decisions about what happens next." Thanks, Hilary, for sharing your story! @guardian #breastcancer #hereditarycancer

https://t.co/LbWqSNMUPe

[iCellate @iCellate]

Europe's #beatingcancerplan has four key action areas, one of which is #prevention. Tomorrow is #worldcancerday and we're talking #cancerprevention across nine different cancer types #ontheblog. Check it out to see what actions you can take! #WCD2023

https://t.co/un8BrydF9r

[iCellate @iCellate]

Gunilla fick veta att hon har en ökad risk för #ärftligcancer.

– Andra kanske tänker annorlunda. Men jag skulle rekommendera att ta reda på riskerna om någon anhörig har blivit sjuk, för du kan få hjälp och stöd innan du själv hinner bli sjuk.

https://t.co/FUpKVc3suR

[iCellate @iCellate]

What a year!

To our colleagues - what an honor to be #fightingcancer with you.

To our collaborators, supporters, and patients - we could not have done it without you! #Thankyou

From all of us iCellate to you, HAPPY HOLIDAYS!

[iCellate @iCellate]

A #hereditarycancer assessment is more than a #genetictest. So what is it? iCellate's #geneticcounselor Anna Hellquist tells us in a refreshed #blogpost!

https://t.co/iC1dfsaTuN

[iCellate @iCellate]

Identifying #hereditarycancer in a family can help greatly with #prevention and #earlydetection. But knowing that a newly diagnosed #cancer is hereditary can benefit the cancer patient, too. Find out how #ontheblog

https://t.co/ZMfo7VSwbk

[iCellate @iCellate]

At-home saliva collection makes #GeneMate accessible to individuals everywhere. And it's easy! #dnatest #hereditarycancer

https://t.co/oFyuHsGzMQ

[iCellate @iCellate]

Meet Francisca Lameiras, our resident #boomerang. Francisca left iCellate in 2019 to travel, and we were happy to receive her back upon her return in 2020. Read why she chose a career in cancer and the winding road she took to get here. #employeeprofile

https://t.co/XDblBVwR5N

[iCellate @iCellate]

Did you know #pancreaticcancer can be hereditary? Read more about what causes pancreatic cancer and signs it might be hereditary #ontheblog. #pancreaticcancerawarenessmonth

https://t.co/lOlX76p5IH

[iCellate @iCellate]

It's #WPCD! #Pancreaticcancer has the highest mortality rate of all major cancers, and most patients are diagnosed late. We need better therapies and diagnostics - the latter of which we are working on! More soon. For now, we hope you'll help us spread #pancreaticcancerawareness!

[iCellate @iCellate]

Meet @HelenaSilCas, Senior Scientist and project leader for iCellate's CTC platform, CellMate! Get to know Helena and what it means to her to work with #cancerdiagnostics. #cancer #employeeprofile #employeeappreciation

https://t.co/1354fNTttg

[iCellate @iCellate]

Big thank you to Lungcancerföreningen, patients, and clinicians for an inspiring and informative meeting for yesterday's #Lungcancerdagen. You can support Lungcancerföreningen by becoming a member or donating at https://t.co/8w5QNWUdcP #lungcancer

[iCellate @iCellate]

https://t.co/CQq2UJ9ifc has been outfitted with a brand new look and loads more information to help you choose the #hereditarycancertest that best suits you. Payment via #Swish now accepted in Sweden. Check it out! #newwebsite #websitelaunch #hereditarycancer #DNAtest